GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

"Not all colon polyps are cancerous but all colon cancer starts as a polyp which is why everyone needs to know about them and ...

A study conducted by Mass General Brigham shows that higher consumption of ultraprocessed foods has led to higher rates of ...

There is a taboo about colon cancer,” the Overland Park native said. “People don’t want to be informed. People want to ignore.” ...

A new study found that women who eat a lot of ultra-processed foods were 1.5 times more likely to develop pre-cancerous polyps before the age of 50, compared to those with healthier diets.

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Scientists have pinpointed a “Big Bang” moment in bowel cancer—when cells first evade the immune system. This early immune ...

A seemingly healthy 29-year-old barber is seeking treatment for stage IV colon cancer through a new program at Vanderbilt.

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...